Urapidil Stragen i.v. 25 mg
Urapidil Stragen i.v. 25 mg is a medicine authorised by Swissmedic under authorisation number 66012. The authorisation holder is Stragen Pharma SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 21 April 2016 and the authorisation is valid without a time limit. ATC code C02CA06 places the medicine in the group Antihypertensives.
| Authorisation number | 66012 |
|---|---|
| Name | Urapidil Stragen i.v. 25 mg |
| Full name | Urapidil Stragen i.v. 25 mg, solution injectable |
| Authorisation holder | Stragen Pharma SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C02CA06 |
| First authorisation | 21 April 2016 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Urapidil Stragen i.v. 25 mg, solution injectable | B | 21 April 2016 |
| 2 | Urapidil Stragen i.v. 50 mg, solution injectable | B | 21 April 2016 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 5 x 5 | ml | C02CA06 | 02.07.1. | B |
| 2 | 5 x 10 | ml | C02CA06 | 02.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Urapidil Stragen i.v. 25 mg authorised in Switzerland?
Yes. Urapidil Stragen i.v. 25 mg is authorised by Swissmedic under authorisation number 66012, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Urapidil Stragen i.v. 25 mg have?
Urapidil Stragen i.v. 25 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Urapidil Stragen i.v. 25 mg?
The authorisation holder is Stragen Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.